885274-05-5 Usage
Description
3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is a chemical compound with the molecular formula C14H25NO5. It is a derivative of morpholine and is characterized by its white solid appearance and a molecular weight of approximately 283.35 g/mol. 3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized as a building block in the synthesis of pharmaceuticals and organic compounds, particularly due to its tert-butyl ester group, which makes it suitable for use in protection and deprotection schemes in organic chemistry reactions. It also serves as a precursor in the preparation of various biologically active molecules.
Uses
Used in Pharmaceutical Synthesis:
3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Organic Chemistry:
In the field of organic chemistry, 3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a reagent in various chemical reactions, taking advantage of its tert-butyl ester group for protection and deprotection schemes.
Used in the Preparation of Biologically Active Molecules:
3-(2-CARBOXY-ETHYL)-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized as a precursor in the preparation of biologically active molecules, which can have potential applications in medicine and other related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 885274-05-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 885274-05:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*4)+(2*0)+(1*5)=205
205 % 10 = 5
So 885274-05-5 is a valid CAS Registry Number.
885274-05-5Relevant articles and documents
DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS
-
Paragraph 0474 - 0477, (2015/06/10)
Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.
